CAD 0.01
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -42 Thousand CAD | 28.81% |
2022 | -59 Thousand CAD | 14.49% |
2021 | -69 Thousand CAD | 22.47% |
2020 | -89 Thousand CAD | 25.21% |
2019 | -119 Thousand CAD | -33.24% |
2018 | -89.31 Thousand CAD | -268.64% |
2017 | -24.22 Thousand CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -9000.00 CAD | 0.0% |
2024 Q2 | -9000.00 CAD | 0.0% |
2023 Q3 | -11 Thousand CAD | 0.0% |
2023 Q1 | -11 Thousand CAD | 35.29% |
2023 Q2 | -11 Thousand CAD | 0.0% |
2023 Q4 | -9000.00 CAD | 18.18% |
2023 FY | -42 Thousand CAD | 28.81% |
2022 Q2 | -15 Thousand CAD | 0.0% |
2022 FY | -59 Thousand CAD | 14.49% |
2022 Q4 | -17 Thousand CAD | -21.43% |
2022 Q3 | -14 Thousand CAD | 6.67% |
2022 Q1 | -15 Thousand CAD | 16.67% |
2021 Q4 | -18 Thousand CAD | 0.0% |
2021 Q1 | -15 Thousand CAD | 0.0% |
2021 Q2 | -18 Thousand CAD | -20.0% |
2021 Q3 | -18 Thousand CAD | 0.0% |
2021 FY | -69 Thousand CAD | 22.47% |
2020 Q4 | - CAD | 0.0% |
2020 FY | -89 Thousand CAD | 25.21% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 FY | -119 Thousand CAD | -33.24% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | -89.31 Thousand CAD | -268.64% |
2017 FY | -24.22 Thousand CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 16.663% |
Asep Medical Holdings Inc | -113.74 Thousand CAD | 63.074% |
BetterLife Pharma Inc. | - CAD | Infinity% |
BioVaxys Technology Corp. | - CAD | Infinity% |
Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 107.455% |
Defence Therapeutics Inc. | -90.92 Thousand CAD | 53.808% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 116.778% |
Gemina Laboratories Ltd. | -93.36 Thousand CAD | 55.017% |
Glow Lifetech Corp. | -505.62 Thousand CAD | 91.693% |
Lexston Life Sciences Corp. | -26.39 Thousand CAD | -59.127% |
Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 109.249% |
Doseology Sciences Inc. | -36.08 Thousand CAD | -16.395% |
MYND Life Sciences Inc. | -332.99 Thousand CAD | 87.387% |
Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 265.322% |
PharmaTher Holdings Ltd. | -711.00 CAD | -5807.173% |
PreveCeutical Medical Inc. | -9856.00 CAD | -326.136% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 107.054% |